Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06037733
What this trial is testing

Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Who this might be right for
Advanced Non-Small Cell Squamous Lung CancerRadiotherapyImmunotherapy
Hubei Cancer Hospital 134
Testing effectiveness (Phase 2)Study completedNCT03573947
What this trial is testing

Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Jeffrey Clarke 46
Testing effectiveness (Phase 2)Ended earlyNCT02485652
What this trial is testing

Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung

Who this might be right for
Non Small Cell Lung Cancer
Hanmi Pharmaceutical Company Limited 162
Early research (Phase 1)Ended earlyNCT03054038
What this trial is testing

Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Carcinoma
Vanderbilt-Ingram Cancer Center 22
Testing effectiveness (Phase 2)Ended earlyNCT00532025
What this trial is testing

Sorafenib in Resected Non-small Cell Lung Carcinoma

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Johannes Gutenberg University Mainz 134
Not applicableStudy completedNCT02719847
What this trial is testing

EBUS TBNA After PET/CT in Diagnosing Patients With Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation Therapy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT01372384
What this trial is testing

Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 6
Early research (Phase 1)Study completedNCT00379132
What this trial is testing

131-I-TM-601 Study in Adults With Solid Tumors

Who this might be right for
Breast CancerNon-Small Cell Lung CancerMelanoma+5 more
TransMolecular 60
Testing effectiveness (Phase 2)UnknownNCT01955421
What this trial is testing

Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc

Who this might be right for
Advanced Stage Non Small Cell Lung Cancer
Sun Yat-sen University 224
Large-scale testing (Phase 3)UnknownNCT00265694
What this trial is testing

Random Trial for Elderly Patients With NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Inje University
Testing effectiveness (Phase 2)Study completedNCT00480831
What this trial is testing

PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 128
Testing effectiveness (Phase 2)Looking for participantsNCT07079475
What this trial is testing

Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)

Who this might be right for
Non-Small Cell Lung Cancer
Dizal Pharmaceuticals 220
Not applicableStudy completedNCT00019201
What this trial is testing

Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
National Cancer Institute (NCI)
Not applicableUnknownNCT04708639
What this trial is testing

Monitoring Alectinib Treatment by Detection of ALK Translocations in Serial Blood Samples From Non-Small Cell Lung Cancer Patients

Who this might be right for
Lung CancerALK Gene MutationResistance, Disease+1 more
Aarhus University Hospital 40
Large-scale testing (Phase 3)Study completedNCT03150875
What this trial is testing

A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 290
Testing effectiveness (Phase 2)Looking for participantsNCT06754930
What this trial is testing

SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 400
Testing effectiveness (Phase 2)Study completedNCT03450330
What this trial is testing

Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Dizal Pharmaceuticals 10
Post-approval studies (Phase 4)Study completedNCT01402089
What this trial is testing

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Who this might be right for
Non Small-cell Lung CancerRenal-cell CancerGastrointestinal Stroma Tumor
Markus Joerger 54
Not applicableNot Yet RecruitingNCT07198620
What this trial is testing

A Real-World Study of IBI351 for KRAS G12C+ NSCLC in China

Who this might be right for
Lung Cancer (NSCLC)
Guangdong Association of Clinical Trials 600
Testing effectiveness (Phase 2)Study completedNCT01296113
What this trial is testing

Chemotherapy for Lung Cancer in HIV-positive Patients

Who this might be right for
Non-small Cell Lung CancerHiv-positive
Intergroupe Francophone de Cancerologie Thoracique 61
Next Page